• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前血清甲状腺球蛋白是甲状腺乳头状癌跳跃转移的一个危险因素。

Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma.

作者信息

Huang Ziyang, Song Muye, Wang Shujie, Huang Jianhao, Shi Hongyan, Huang Yijie, Yin Ying, Liu Yongchen, Wu Zeyu

机构信息

Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Shantou University Medical College, Shantou 515041, China.

出版信息

Ann Transl Med. 2020 Mar;8(6):389. doi: 10.21037/atm.2019.10.92.

DOI:10.21037/atm.2019.10.92
PMID:32355833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7186689/
Abstract

BACKGROUND

Lymph node metastasis of papillary thyroid carcinoma (PTC) was a significant risk factor of local recurrence and distant metastasis, and our study aimed to identify predictive factors of skip metastasis in PTC, helping surgeons to build a strategy when facing patients in N1b stage with clinical central lymph node-negative.

METHODS

A total of 304 patients who underwent total thyroidectomy with central and lateral lymph node dissection and were diagnosed PTC with lateral lymph node metastasis (LLNM) in the Department of General Surgery at Guangdong Provincial People's Hospital were enrolled. We collected clinicopathological characteristics and analyzed their correlation with skip metastasis by univariate and multivariate analysis.

RESULTS

The incidence of skip metastasis in PTC was 14.8%. Univariate analysis showed that age, tumor diameter, primary tumor location, and preoperative serum thyroglobulin (Tg) were risk factors. Age (P=0.049, OR =3.418), primary tumor location (P<0.001, OR =7.279), and Tg (P=0.038, OR =9.412) were independent predictors in PTC by multivariate analysis.

CONCLUSIONS

Skip metastasis of PTC was significantly associated with preoperative serum Tg ≤77 ng/mL, tumor diameter ≤10 mm, age ≥55, and tumor located in the upper lobe. It is the first time to demonstrate that Tg is associated with skip metastasis of PTC.

摘要

背景

甲状腺乳头状癌(PTC)的淋巴结转移是局部复发和远处转移的重要危险因素,本研究旨在确定PTC中跳跃转移的预测因素,帮助外科医生在面对临床中央淋巴结阴性的N1b期患者时制定策略。

方法

选取广东省人民医院普通外科304例行全甲状腺切除术并进行中央和侧方淋巴结清扫且诊断为PTC伴侧方淋巴结转移(LLNM)的患者。收集临床病理特征,并通过单因素和多因素分析其与跳跃转移的相关性。

结果

PTC中跳跃转移的发生率为14.8%。单因素分析显示年龄、肿瘤直径、原发肿瘤位置和术前血清甲状腺球蛋白(Tg)是危险因素。多因素分析显示年龄(P=0.049,OR =3.418)、原发肿瘤位置(P<0.001,OR =7.279)和Tg(P=0.038,OR =9.412)是PTC跳跃转移的独立预测因素。

结论

PTC的跳跃转移与术前血清Tg≤77 ng/mL、肿瘤直径≤10 mm、年龄≥55岁及肿瘤位于上叶显著相关。首次证明Tg与PTC的跳跃转移有关。

相似文献

1
Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma.术前血清甲状腺球蛋白是甲状腺乳头状癌跳跃转移的一个危险因素。
Ann Transl Med. 2020 Mar;8(6):389. doi: 10.21037/atm.2019.10.92.
2
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.甲状腺乳头状癌的隐匿性转移在临床实践中难以预测。
BMC Cancer. 2017 Oct 25;17(1):702. doi: 10.1186/s12885-017-3698-2.
3
Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma.传统型乳头状甲状腺癌侧方淋巴结转移的预测因素
Gland Surg. 2020 Aug;9(4):1000-1007. doi: 10.21037/gs-20-482.
4
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.甲状腺乳头状癌侧颈淋巴结跳跃转移的危险因素及预测模型。
World J Surg. 2020 May;44(5):1498-1505. doi: 10.1007/s00268-019-05332-0.
5
PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.位于上极的甲状腺乳头状癌更容易发生侧方淋巴结转移和跳跃转移。
World J Surg Oncol. 2020 Jul 28;18(1):188. doi: 10.1186/s12957-020-01965-x.
6
Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.构建基于甲状腺结节和细针穿刺活检可疑侧颈部淋巴结分布的列线图预测甲状腺乳头状癌转移。
Front Endocrinol (Lausanne). 2023 Nov 28;14:1242061. doi: 10.3389/fendo.2023.1242061. eCollection 2023.
7
[Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma].[甲状腺乳头状癌跳跃性侧颈淋巴结转移的危险因素]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Jul;36(7):528-532;539. doi: 10.13201/j.issn.2096-7993.2022.07.010.
8
Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.基于临床和超声特征预测甲状腺乳头状癌侧颈部淋巴结跳跃转移。
Front Endocrinol (Lausanne). 2023 May 9;14:1151505. doi: 10.3389/fendo.2023.1151505. eCollection 2023.
9
Predictive Factors for Skip Lymph Node Metastasis and Their Implication on Recurrence in Papillary Thyroid Carcinoma.甲状腺乳头状癌跳跃淋巴结转移的预测因素及其对复发的影响
Biomedicines. 2022 Jan 16;10(1):179. doi: 10.3390/biomedicines10010179.
10
Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌跳跃性侧颈淋巴结转移的危险因素。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):493-498. doi: 10.1007/s00405-020-06176-4. Epub 2020 Jun 30.

引用本文的文献

1
The role of preoperative serum thyroglobulin in the diagnosis and treatment of differentiated thyroid cancer: a systematic review and meta-analysis.术前血清甲状腺球蛋白在分化型甲状腺癌诊断与治疗中的作用:一项系统评价与Meta分析
Front Oncol. 2024 Dec 24;14:1426785. doi: 10.3389/fonc.2024.1426785. eCollection 2024.
2
The alternative value of thyroid stimulating hormone instead of thyroglobulin in differentiation of follicular thyroid neoplasm in Hashimoto's thyroiditis.促甲状腺激素替代甲状腺球蛋白在桥本甲状腺炎中鉴别滤泡性甲状腺肿瘤的价值
Front Oncol. 2024 Sep 9;14:1395202. doi: 10.3389/fonc.2024.1395202. eCollection 2024.
3
Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.预后营养指数预测甲状腺乳头状癌的侧颈部淋巴结转移和无复发生存。
BMC Cancer. 2024 Aug 22;24(1):1039. doi: 10.1186/s12885-024-12801-w.
4
Detection of thyroglobulin for diagnosis of metastatic lateral cervical lymph nodes in papillary thyroid carcinoma: accuracy and application in clinical practice.检测甲状腺球蛋白用于诊断甲状腺乳头状癌侧颈部转移性淋巴结:准确性及在临床实践中的应用
Transl Cancer Res. 2024 Feb 29;13(2):1043-1051. doi: 10.21037/tcr-23-1490. Epub 2024 Feb 2.
5
Risk factors and nomogram to predict skip metastasis in papillary thyroid carcinoma.预测甲状腺乳头状癌跳跃转移的危险因素及列线图
Gland Surg. 2024 Feb 29;13(2):178-188. doi: 10.21037/gs-23-376. Epub 2024 Feb 23.
6
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.分析影响甲状腺乳头状癌预后的相关因素并构建生存模型。
Cancer Med. 2023 Apr;12(7):7868-7876. doi: 10.1002/cam4.5555. Epub 2022 Dec 22.
7
The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.甲状腺球蛋白在分化型甲状腺癌患者术前和术后评估中的作用。
Front Endocrinol (Lausanne). 2022 Jun 2;13:872527. doi: 10.3389/fendo.2022.872527. eCollection 2022.
8
A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.一种用于筛选甲状腺乳头状癌中阴性中央淋巴结转移患者跳跃转移的特定预测模型。
Front Endocrinol (Lausanne). 2021 Sep 30;12:743900. doi: 10.3389/fendo.2021.743900. eCollection 2021.
9
Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.术前预测桥本甲状腺炎合并甲状腺乳头状癌患者中央区淋巴结转移
Front Endocrinol (Lausanne). 2021 Jul 22;12:713475. doi: 10.3389/fendo.2021.713475. eCollection 2021.
10
A comprehensive expression profile of tRNA-derived fragments in papillary thyroid cancer.甲状腺癌中 tRNA 衍生片段的综合表达谱。
J Clin Lab Anal. 2021 Mar;35(3):e23664. doi: 10.1002/jcla.23664. Epub 2020 Dec 17.

本文引用的文献

1
Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.分化型甲状腺癌中跳跃性转移至侧颈淋巴结:一项系统评价
BMC Surg. 2019 Apr 24;18(Suppl 1):112. doi: 10.1186/s12893-018-0435-y.
2
Genetic Variants in the Gene Are Associated with Thyroglobulin Plasma Level in Healthy Individuals.基因中的遗传变异与健康个体的甲状腺球蛋白血浆水平相关。
Thyroid. 2019 Jun;29(6):886-893. doi: 10.1089/thy.2018.0661. Epub 2019 May 13.
3
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
4
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
5
Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer: a retrospective cohort study.评估术前血清甲状腺球蛋白在分化型甲状腺癌中的应用价值:一项回顾性队列研究。
Endocrine. 2018 Sep;61(3):506-510. doi: 10.1007/s12020-018-1643-z. Epub 2018 Jun 15.
6
Predictive Factors of Skip Metastasis in Papillary Thyroid Cancer.甲状腺乳头状癌跳跃性转移的预测因素。
Med Sci Monit. 2018 May 3;24:2744-2749. doi: 10.12659/MSM.907357.
7
Thyroglobulin measurement in the management of patients with differentiated thyroid cancer.甲状腺球蛋白在分化型甲状腺癌患者管理中的应用。
Crit Rev Clin Lab Sci. 2018 May;55(3):205-218. doi: 10.1080/10408363.2018.1450830. Epub 2018 Mar 16.
8
Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.N1b 期甲状腺乳头状癌治疗后复发的危险因素。
Ann Surg. 2019 May;269(5):966-971. doi: 10.1097/SLA.0000000000002710.
9
A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.基于转移淋巴结特征的列线图预测甲状腺乳头状癌复发。
Thyroid. 2018 Mar;28(3):301-310. doi: 10.1089/thy.2017.0422.
10
Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer.术前血清甲状腺球蛋白可预测分化型甲状腺癌患者的初始远处转移。
Sci Rep. 2017 Dec 5;7(1):16955. doi: 10.1038/s41598-017-17176-6.